List of insiders holdings for Aquestive Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | BRATTON DOUGLAS K MonoLine Partners L.P. MonoLine RX L.P. MonoLine RX II L.P. MonoLine RX III L.P. MonoSol Rx Genpar L.P. MRX Partners LLC Bratton Capital Inc. Bratton Capital Management L.P. 10% Owner | 2025-02-13 11:38:04 | 10,077,434 0 | 10,077,434 | Form 13G |
| 2 | BRATTON DOUGLAS K 10% Owner | 2025-02-13 11:38:04 | 10,077,434 0 | 10,077,434 | Form 13G |
| 3 | Barber Daniel President and CEO | 2026-03-11 12:52:40 | 1,527,753 0 | 1,527,753 | Form 4 |
| 4 | Schobel Alexander Mark Chief Innovation/Tech Officer | 2024-10-02 14:16:27 | 980,726 0 | 980,726 | Form 4/A |
| 5 | BRAENDER LORI J Chief Legal Officer | 2026-03-11 12:52:26 | 492,879 0 | 492,879 | Form 4 |
| 6 | TOTH A ERNEST JR Chief Financial Officer | 2026-03-11 12:51:44 | 446,112 0 | 446,112 | Form 4 |
| 7 | Wargacki Stephen Chief Science Officer | 2025-03-11 17:49:10 | 408,552 0 | 408,552 | Form 4 |
| 8 | Boyd Peter E. Chief People Officer | 2026-03-11 12:52:57 | 381,009 0 | 381,009 | Form 4 |
| 9 | Kendall Keith J CEO and President | 2022-03-14 11:24:23 | 375,000 0 | 375,000 | Form 4 |
| 10 | Cioffi Melina SVP, Regulatory Affairs | 2026-03-11 12:52:15 | 349,867 0 | 349,867 | Form 4 |
| 11 | Jung Cassie Chief Operating Officer | 2026-03-11 12:50:43 | 317,480 2,000 | 319,480 | Form 4 |
| 12 | Korczynski Sherry Chief Commercial Officer | 2026-03-11 12:51:23 | 283,617 0 | 283,617 | Form 4 |
| 13 | Kraus Carl N Chief Medical Officer | 2025-10-17 14:01:00 | 282,475 0 | 282,475 | Form 4 |
| 14 | Maxwell John T. SVP-Chief Financial Officer | 2020-08-19 08:55:53 | 150,614 0 | 150,614 | Form 4 |
| 15 | Davis Matthew W. Chief Development Officer | 2026-03-11 12:49:56 | 150,000 0 | 150,000 | Form 4 |
| 16 | Cochran John Director | 2025-06-12 13:58:00 | 141,486 0 | 141,486 | Form 4 |
| 17 | Greenhawt Matthew J. Chief Medical Officer | 2026-03-11 09:25:59 | 125,000 2,000 | 127,000 | Form 4 |
| 18 | BROWN GREGORY B Director | 2025-06-12 14:13:31 | 117,085 0 | 117,085 | Form 4 |
| 19 | Truitt Kenneth Chief Medical Officer | 2022-09-08 16:30:27 | 100,000 0 | 100,000 | Form 4 |
| 20 | Marshall Ken W. SVP, Chief Commercial Officer | 2023-08-09 16:30:32 | 75,000 0 | 75,000 | Form 4 |
| 21 | Wood Theresa SVP-HR and Org. Development | 2022-03-14 11:26:29 | 70,000 0 | 70,000 | Form 4 |
| 22 | COSTA SANTO J Director | 2024-06-21 13:50:10 | 55,327 0 | 55,327 | Form 4 |
| 23 | Scibetta James S Director | 2021-06-17 18:51:00 | 51,635 0 | 51,635 | Form 4 |
| 24 | Slatko Gary H SVP, Chief Medical Officer | 2020-03-18 16:48:39 | 50,000 0 | 50,000 | Form 4 |
| 25 | Jenkins Abigail L. Director | 2025-06-12 13:59:05 | 42,000 0 | 42,000 | Form 4 |
| 26 | MORRIS TIMOTHY E Director | 2025-06-12 13:59:22 | 42,000 0 | 42,000 | Form 4 |
| 27 | Krop Julie Director | 2025-06-12 13:59:37 | 42,000 0 | 42,000 | Form 4 |
| 28 | Taglietti Marco Director | 2025-06-12 13:57:23 | 42,000 0 | 42,000 | Form 4 |
| 29 | Lurker Nancy Director | 2021-06-17 18:51:09 | 20,000 0 | 20,000 | Form 4 |